794 results on '"Sastre-Garriga, Jaume"'
Search Results
2. Optic Nerve Imaging in Multiple Sclerosis and Related Disorders
3. Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study
4. Optic chiasm manual and automated measurements in sub-acute optic neuritis with OCT and MRI correlations
5. Longitudinal stability of inter-eye differences in optical coherence tomography measures for identifying unilateral optic nerve lesions in multiple sclerosis
6. Validation of the Spanish version of DYsphagia in MUltiple Sclerosis questionnaire (DYMUS)
7. Expert-Agreed Practical Recommendations on the Use of Cladribine
8. Assessment of 2D conventional and synthetic MRI in multiple sclerosis
9. Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRI
10. Prognosis of a second clinical event from baseline MRI in patients with a CIS: a multicenter study using a machine learning approach
11. Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre
12. Spinal cord grey matter atrophy in Multiple Sclerosis clinical practice
13. The ageing central nervous system in multiple sclerosis: the imaging perspective.
14. Detection of lesions in the optic nerve with magnetic resonance imaging using a 3D convolutional neural network
15. Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients
16. Artificial intelligence applied to MRI data to tackle key challenges in multiple sclerosis
17. Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab
18. Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
19. 2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
20. Adding brain volume measures into response criteria in multiple sclerosis: the Río-4 score
21. Value of Optic NerveMRI in Multiple Sclerosis Clinical Management: A MAGNIMS Position Paper and Future Perspectives.
22. Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRI.
23. Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis.
24. Prediction of disease activity and treatment failure in relapsing–remitting MS patients initiating daily oral DMTs
25. Optic nerve topography in multiple sclerosis diagnostic criteria: Existing knowledge and future directions
26. Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria
27. A validation study of manual atrophy measures in patients with Multiple Sclerosis
28. Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
29. Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.
30. CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
31. Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis
32. The hippocampus in multiple sclerosis
33. The role of the cerebellum in multiple sclerosis—150 years after Charcot
34. Correction to: Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre
35. Optic nerve region in multiple sclerosis diagnosis: the utility of visual evoked potentials
36. Brain regional volume estimations with NeuroQuant and FIRST: a study in patients with a clinically isolated syndrome
37. Treatment of multiple sclerosis — success from bench to bedside
38. Correction to: Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients
39. Optic Nerve Topography in Multiple Sclerosis Diagnosis: The Utility of Visual Evoked Potentials
40. A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients
41. MOG antibodies in adults with a first demyelinating event suggestive of multiple sclerosis
42. Prognostic value of single-subject grey matter networks in early multiple sclerosis
43. Views of Multiple Sclerosis Patients About Key Elements for a Decision Aid: A Qualitative Study
44. Association of Very Early Treatment Initiation With the Risk of Long-Term Disability in Patients With a First Demyelinating Event
45. Corrigendum to “Longitudinal stability of inter-eye differences in optical coherence tomography measures for identifying unilateral optic nerve lesions in multiple sclerosis” [Journal of the Neurological Sciences 449C (2023) Start page–End page/JOTNS D-23-00048R2]
46. Performance of five research-domain automated WM lesion segmentation methods in a multi-center MS study
47. Brain Atrophy in Multiple Sclerosis: Clinical Relevance and Technical Aspects
48. T1/T2-weighted ratio: A feasible MRI biomarker in multiple sclerosis.
49. Prognostic value of single-subject grey matter networks in early multiple sclerosis.
50. Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple Sclerosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.